Accutane (Isotretinoin) Anesthesia and Perioperative Interaction: What Patients and Clinicians Must Know

Does isotretinoin have a labeled interaction with anesthetic drugs?

The Absorica and Absorica LD label has a drug interactions section that names vitamin A, tetracyclines and oral contraceptives [1]. Anesthetic agents are not listed in that section. The label says to avoid vitamin A supplements because isotretinoin is closely related to vitamin A [1]. It says to avoid tetracyclines because isotretinoin has been associated with intracranial hypertension, and some cases involved tetracycline use [1]. For oral contraceptives, a study in the label found no clinically significant change in norethindrone and ethinyl estradiol pharmacokinetics when given with isotretinoin [1].

What label effects matter around the airway?

The Absorica label lists dry lips, dry skin, dry eye, epistaxis, chapped lips and cheilitis among the most common adverse reactions, with an incidence of 5% or greater [1]. Nasal dryness appears in the Absorica adverse reaction list, and dry mouth appears in the older-format isotretinoin label [1][2].

What about liver tests and wound healing?

The label lists hepatotoxicity as a warning and calls for liver function tests before and during treatment [1]. It also calls for a fasting lipid profile in all patients [1]. The adverse reaction section lists increased ALT, AST, alkaline phosphatase, bilirubin and triglycerides [1].

The label lists abnormal wound healing, described as delayed healing or exuberant granulation tissue with crusting, as an adverse reaction [1][2]. It says to avoid wax epilation and skin resurfacing procedures such as dermabrasion and laser during treatment and for at least 6 months afterward because of scarring [1][2]. A case series described six patients who developed atypical keloids after dermabrasion while on or shortly after isotretinoin; the authors recommended delaying dermabrasion in those patients [3]. That report concerns dermabrasion, not general surgical incisions.

Bleeding, bruising and muscle injury

The label lists bruising, thrombocytopenia and increased platelet counts among adverse reactions [1]. Creatine phosphokinase is listed among laboratory abnormalities, and rhabdomyolysis is a rare reported reaction [1][2]. These are label listings rather than measurements of surgical bleeding or anesthetic risk.